Fate Therapeutics Inc
NASDAQ:FATE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fate Therapeutics Inc
NASDAQ:FATE
|
US |
|
M
|
Marcventures Holdings Inc
XPHS:MARC
|
PH |
|
Blue Moon Metals Inc
XTSX:MOON
|
CA |
|
A
|
Asia Grocery Distribution Ltd
HKEX:8413
|
HK |
|
L
|
Levinstein Properties Ltd
TASE:LVPR
|
IL |
|
P
|
Pruksa Holding PCL
SET:PSH
|
TH |
|
Nucleus Software Exports Ltd
NSE:NUCLEUS
|
IN |
|
Mugen Estate Co Ltd
TSE:3299
|
JP |
|
Mphasis Ltd
NSE:MPHASIS
|
IN |
|
Digital Brands Group Inc
NASDAQ:DBGI
|
US |
|
C
|
Cleen Energy AG
VSE:CLEN
|
AT |
|
W
|
Winpak Ltd
TSX:WPK
|
CA |
|
Mewah International Inc
SGX:MV4
|
SG |
Shareholder Yield
Current shareholder yield for FATE is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
FATE Price
Fate Therapeutics Inc
| Average Annual Return | -57.14% |
| Standard Deviation of Annual Returns | 23.57% |
| Max Drawdown | -99% |
| Market Capitalization | 138.4m USD |
| Shares Outstanding | 116 260 000 |
| Percentage of Shares Shorted | 9.13% |
